Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Sep-24 6:44 PM View:  | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 25-Sep-24 | Sale (Planned) | 600 | $24.01 | $14,406.00 | (< 1%) 1.48M to 1.48M | |
| 25-Sep-24 6:44 PM View: | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 24-Sep-24 | Sale (Planned) | 1,055 | $24.02 | $25,340.70 | (< 1%) 1.48M to 1.48M | |
| 25-Sep-24 6:44 PM View: | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 23-Sep-24 | Private Sale (Planned) | 10,092 | $24.13 | $243,477.00 | (< 1%) 1.49M to 1.48M | |
| 20-Sep-24 6:24 PM View: | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 20-Sep-24 | Sale (Planned) | 7,109 | $24.19 | $171,950.00 | (< 1%) 1.5M to 1.49M | |
| 20-Sep-24 6:24 PM View: | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 19-Sep-24 | Sale (Planned) | 5,698 | $24.31 | $138,491.00 | (< 1%) 1.5M to 1.5M | |
| 20-Sep-24 6:24 PM View: | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 18-Sep-24 | Private Sale (Planned) | 3,500 | $24.00 | $84,000.00 | (< 1%) 1.51M to 1.5M | |
| 17-Sep-24 5:15 PM View: | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 13-Sep-24 | Grant | 1,350 | $6.58 | $8,881.65 | < 1% 1.5M to 1.51M | |
| 17-Sep-24 5:12 PM View: | Fuhrman Alan Chief Financial Officer | Tyra Biosciences, Inc. (TYRA) | 13-Sep-24 | Grant | 954 | $12.48 | $11,904.00 | 40% 2.4K to 3.35K | (2%) |
| 10-Jun-24 7:10 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 10-Jun-24 | Sale (Planned) | 3,502 | $20.00 | $70,044.90 | (< 1%) 431.48K to 427.98K | |
| 10-Jun-24 7:10 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 07-Jun-24 | Private Sale (Planned) | 200 | $20.00 | $4,000.00 | (< 1%) 431.68K to 431.48K | |
| 19-Mar-24 7:38 PM View: | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 15-Mar-24 | Grant | 1,880 | $6.58 | $12,368.50 | < 1% 1.5M to 1.5M | |
| 19-Mar-24 7:58 PM View: | Tada Hiroomi Chief Medical Officer | Tyra Biosciences, Inc. (TYRA) | 15-Mar-24 | Grant | 1,968 | $6.58 | $12,947.50 | 2% 84.47K to 86.44K | |
| 19-Mar-24 8:01 PM View: | Fuhrman Alan Chief Financial Officer | Tyra Biosciences, Inc. (TYRA) | 15-Mar-24 | Grant | 932 | $12.48 | $11,629.50 | 64% 1.46K to 2.4K | (2%) |
| 13-Mar-24 5:46 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 11-Mar-24 | Private Sale (Planned) | 200 | $20.00 | $4,000.00 | (< 1%) 431.88K to 431.68K | |
| 08-Mar-24 5:38 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 07-Mar-24 | Sale (Planned) | 68 | $20.00 | $1,360.00 | (< 1%) 431.95K to 431.88K | |
| 08-Mar-24 5:38 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 06-Mar-24 | Private Sale (Planned) | 1,733 | $20.09 | $34,819.40 | (< 1%) 433.68K to 431.95K | |
| 05-Mar-24 5:40 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 05-Mar-24 | Sale (Planned) | 1,189 | $20.02 | $23,802.50 | (< 1%) 434.87K to 433.68K | |
| 05-Mar-24 5:40 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 04-Mar-24 | Sale (Planned) | 5,063 | $20.08 | $101,654.00 | (1%) 439.94K to 434.87K | |
| 05-Mar-24 5:40 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 01-Mar-24 | Private Sale (Planned) | 2,900 | $20.04 | $58,111.90 | (< 1%) 442.84K to 439.94K | |
| 29-Feb-24 6:58 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 29-Feb-24 | Sale (Planned) | 2,050 | $20.00 | $41,003.30 | (< 1%) 444.89K to 442.84K | |
| 29-Feb-24 6:58 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 28-Feb-24 | Sale (Planned) | 5,849 | $20.13 | $117,729.00 | (1%) 450.74K to 444.89K | |
| 29-Feb-24 6:58 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 27-Feb-24 | Private Sale (Planned) | 745 | $20.00 | $14,900.00 | (< 1%) 451.48K to 450.74K | |
| 14-Feb-24 9:00 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 12-Feb-24 | Private Sale (Planned) | 1,501 | $20.00 | $30,020.00 | (< 1%) 452.98K to 451.48K | |
| 09-Feb-24 7:26 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 07-Feb-24 | Private Sale (Planned) | 9,587 | $18.09 | $173,466.00 | (2%) 462.57K to 452.98K | |
| 06-Feb-24 8:23 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 06-Feb-24 | Sale (Planned) | 15,413 | $18.09 | $278,827.00 | (3%) 477.98K to 462.57K | |
| 08-Feb-24 5:16 PM View: | Ra Capital Management, LLC Director 10% Owner | Tyra Biosciences, Inc. (TYRA) | 06-Feb-24 | Grant | 3,180,160 | $13.01 | $41,373,800.00 | 44% 7.24M to 10.42M | (6%) |
| 08-Feb-24 5:09 PM View: | Boxer Capital, LLC | Tyra Biosciences, Inc. (TYRA) | 06-Feb-24 | Grant | 63,412 | $13.01 | $824,990.00 | < 1% 6.47M to 6.53M | (6%) |
| 06-Feb-24 8:22 PM View: | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 05-Feb-24 | Sale (Planned) | 13,817 | $16.97 | $234,430.00 | (< 1%) 1.52M to 1.5M | |
| 06-Feb-24 8:23 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 02-Feb-24 | Option Exercise | 25,393 | $0.61 | $15,489.70 | 5% 527.98K to 553.37K | |
| 06-Feb-24 8:23 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 02-Feb-24 | Planned Option Sale | 25,393 | $16.33 | $414,644.00 | (5%) 553.37K to 527.98K | |
| 06-Feb-24 8:22 PM View: | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 02-Feb-24 | Private Sale (Planned) | 86,183 | $16.50 | $1,421,650.00 | (5%) 1.6M to 1.52M | |
| 06-Feb-24 8:23 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 02-Feb-24 | Sale (Planned) | 50,000 | $16.33 | $816,453.00 | (9%) 527.98K to 477.98K | |
| 19-Sep-23 7:37 PM View: | Tada Hiroomi Chief Medical Officer | Tyra Biosciences, Inc. (TYRA) | 15-Sep-23 | Grant | 1,337 | $6.58 | $8,796.12 | 2% 83.13K to 84.47K | |
| 19-Sep-23 7:27 PM View: | Fuhrman Alan Chief Financial Officer | Tyra Biosciences, Inc. (TYRA) | 15-Sep-23 | Grant | 1,463 | $12.50 | $18,292.60 | 100% 0 to 1.46K | (3%) |
| 19-Sep-23 7:36 PM View: | Harris Todd President and CEO Director | Tyra Biosciences, Inc. (TYRA) | 15-Sep-23 | Grant | 1,421 | $6.58 | $9,348.76 | < 1% 1.6M to 1.6M | |
| 21-Jul-23 8:52 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 21-Jul-23 | Planned Option Sale | 3,900 | $16.01 | $62,427.70 | (< 1%) 531.88K to 527.98K | |
| 21-Jul-23 8:52 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 21-Jul-23 | Option Exercise | 3,900 | $0.61 | $2,379.00 | < 1% 527.98K to 531.88K | |
| 21-Jul-23 8:52 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 19-Jul-23 | Planned Option Sale | 207 | $16.08 | $3,327.53 | (< 1%) 528.19K to 527.98K | |
| 21-Jul-23 8:52 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 19-Jul-23 | Option Exercise | 207 | $0.61 | $126.27 | < 1% 527.98K to 528.19K | |
| 17-Jul-23 7:35 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 17-Jul-23 | Planned Option Sale | 1,900 | $16.03 | $30,464.00 | (< 1%) 529.88K to 527.98K | |
| 17-Jul-23 7:35 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 17-Jul-23 | Option Exercise | 1,900 | $0.61 | $1,159.00 | < 1% 527.98K to 529.88K | |
| 17-Jul-23 7:35 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 13-Jul-23 | Planned Option Sale | 500 | $16.13 | $8,065.00 | (< 1%) 528.48K to 527.98K | |
| 17-Jul-23 7:35 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 13-Jul-23 | Option Exercise | 500 | $0.61 | $305.00 | < 1% 527.98K to 528.48K | |
| 12-Jul-23 6:41 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 12-Jul-23 | Planned Option Sale | 201 | $16.23 | $3,262.31 | (< 1%) 528.18K to 527.98K | |
| 12-Jul-23 6:41 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 12-Jul-23 | Option Exercise | 201 | $0.61 | $122.61 | < 1% 527.98K to 528.18K | |
| 12-Jul-23 6:41 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 11-Jul-23 | Planned Option Sale | 500 | $16.02 | $8,009.50 | (< 1%) 528.48K to 527.98K | |
| 12-Jul-23 6:41 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 11-Jul-23 | Option Exercise | 500 | $0.61 | $305.00 | < 1% 527.98K to 528.48K | |
| 12-Jul-23 6:41 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 10-Jul-23 | Planned Option Sale | 1,202 | $16.01 | $19,240.30 | (< 1%) 529.18K to 527.98K | |
| 12-Jul-23 6:41 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 10-Jul-23 | Option Exercise | 1,202 | $0.61 | $733.22 | < 1% 527.98K to 529.18K | |
| 03-Jul-23 5:31 PM View: | Bensen Daniel Chief Operating Officer | Tyra Biosciences, Inc. (TYRA) | 03-Jul-23 | Option Sale | 400 | $17.03 | $6,814.00 | (< 1%) 532.25K to 531.85K |
